Icogenex

A Seattle-based privately held biotechnology company identifying and developing therapeutic compounds for the treatment of human disease, founded in 1995, Icogen was renamed Icogenex in 2003. The Company's operations have been financed through investments, contracts, and grant support from the Natio... Read more